EndoSphere

About:

Endosphere develops non-invasive medical devices used for treating metabolic diseases.

Website: http://www.EndosphereInc.com

Top Investors: Ohio Department of Development, Rev1 Ventures, North Coast Ventures, Queen City Angels, Ohio TechAngels Fund

Description:

Endosphere is a developer of the novel endo-metabolic device category that provides non-invasive endoscopic therapies for gastrointestinal (GI) disorders and metabolic diseases including obesity, non-alcoholic fatty liver disease, type 2 diabetes, and drug delivery. It treats obesity using the body's natural physiology that enables patients to safely and effectively lose weight without the need for surgery or medications. Endosphere was founded in 2006 and is headquartered in Columbus, Ohio.

Total Funding Amount:

$14.1M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Columbus, Ohio, United States

Founded Date:

2006-01-01

Founders:

Kenneth Binmoeller

Number of Employees:

1-10

Last Funding Date:

2016-10-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai